Are you a new member? Sign up now
Login area
| Sign up
close
ELISONE - 0.1% - 15g
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D07AC13 | G | Mometasone furoate - 0.1% | 6905 | 218696/10 | ELISONE | 0.1% | 15g | Cream | Topical | Germanos Health Care Supplies SARL | Amman Pharmaceutical Industries Co | Jordan | 249,955 L.L | 23.08 | A1 | Amman Pharmaceutical Industries Co | Jordan | 2/5/2024 | 0 |
Drug Substitutes
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D07AC13 | G | Mometasone furoate - 1mg/g | 3559 | 194793/05 | ELICA | 0.1% | 30g | Cream | Topical | The Lebanese Pharmacists SAL | Jamjoum Pharmaceuticals | Saudi Arabia | 341,336 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| D07AC13 | G | Mometasone furoate - 0.1% | 10136 | 85419/1 | ELISONE | 0.1% | 30g | Cream | Topical | Germanos Health Care Supplies SARL | Amman Pharmaceutical Industries | Jordan | 435,405 L.L | 23.08 | A1 | Amman Pharmaceutical Industries | Jordan | 2/5/2024 | 0 |
| D07AC13 | G | Mometasone furoate - 0.1% | 6027 | 221948/09 | METASONE | 0.1% | 30g | Cream | Topical | Medapharm Healthcare SAL | Mediphar Laboratories | Lebanon | 335,321 L.L | 23.08 | A1 | 2/5/2024 | 0 | ||
| D07AC13 | G | Mometasone furoate - 0.1% | 7539 | 186286/13 | XEMADERM | 0.1% | 30g | Cream | Topical | Pharmanet Drugstore S.A.R.L. | Julphar | United Arab Emirates | 335,961 L.L | 23.08 | A1 | Julphar | United Arab Emirates | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024